Circadian rhythms in obsessive-compulsive disorder

Journal of Neural Transmission

Volumn 119, Issue 10, 2012, Pages 1077-1083

  Lange, Klaus W ^a,b   Lange, Katharina M ^a   Hauser, Joachim ^a   Tucha, Lara ^b   Tucha, Oliver ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Agomelatine; Chronotherapy; Circadian rhythm; Delayed sleep phase; Hormone dysregulation; Obsessive compulsive disorder (OCD)

Indexed keywords

AGOMELATINE; FLUOXETINE; HORMONE;

CHRONOTHERAPY; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DRUG EFFICACY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REM SLEEP; REVIEW; SEROTONINERGIC SYSTEM;

ACETAMIDES; ANIMALS; CHRONOBIOLOGY DISORDERS; HORMONES; HUMANS; HYPNOTICS AND SEDATIVES; OBSESSIVE-COMPULSIVE DISORDER; SLEEP DISORDERS;

EID: 84867329088     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0805-z     Document Type: Review

References (85)

1. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW (1992) Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 49:9-20
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington DC
3. Bailly D, Servant D, Dewailly D, Beuscart R, Racadot A, Fossati P, Parquet PJ (1994) Corticotropin releasing factor stimulation test in obsessive compulsive disorder. Biol Psychiatry 35:143-146
4. Bernardi F, Casarosa E, Pluchino N, Palumbo M, Genazzani AD, Luisi S, Genazzani AR (2005) Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and betaendorphin. Fertil Steril 83(Suppl 1):1161-1168
5. Bigos KL, Folan MM, Jones MR, Haas GL, Kroboth FJ, Kroboth PD (2009) Dysregulation of neurosteroids in obsessive compulsive disorder. J Psychiatr Res 43:442-445
6. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF (2006) A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622-632
7. Bobdey M, Fineberg N, Gale T, Patel A, Davies HA (2001) Reported sleep patterns in obsessive-compulsive disorder. Int J Psychiatry Clin Pract 6:15-21
8. Bosler O, Beaudet A (1985) VIP neurons as prime synaptic targets for serotonin afferents in rat suprachiasmatic nucleus: A combined radioautographic and immunocytochemical study. J Neurocytol 14:749-763
9. Catapano F, Monteleone P, Maj M, Kemali D (1990) Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 23:53-56
10. Catapano F, Monteleone P, Fuschino A, Maj M, Kemali D (1992) Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder. Psychiatry Res 44:217-225
11. Centorrino F, Hennen J, Mallya G, Egli S, Clark T, Baldessarini RJ (2006) Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both. Hum Psychopharmacol 21:189-193
12. Chappell P, Leckman J, Goodman W, Bissette G, Pauls D, Anderson G, Riddle M, Scahill L, McDougle C, Cohen D (1996) Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: Comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry 39:776-783
13. Coles ME, Sharkey KM (2011) Compulsion or chronobiology? A case of severe obsessive-compulsive disorder treated with cognitive-behavioral therapy augmented with chronotherapy. J Clin Sleep Med 7:307-309
14. Coles ME, Heimberg RG, Frost RO, Steketee G (2005) Not just right experiences and obsessive-compulsive features: Experimental and self-monitoring perspectives. Behav Res Ther 43:153-167
15. Compagnone NA, Mellon SH (2000) Neurosteroids: Biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21:1-56
16. Coryell WH, Black DW, Kelly MW, Noyes R Jr (1989) HPA axis disturbance in obsessive-compulsive disorder. Psychiatry Res 30:243-251
17. Cottraux JA, Bouvard M, Claustrat B, Juenet C (1984) Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: A confirmatory report. Psychiatry Res 13:157-165
18. da Rocha FF, Correa H (2007) Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31: 1550-1551
19. da Rocha FF, Correa H (2011) Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD. Clin Neuropharmacol 34:139-140
20. Dagan Y, Eisenstein M (1999) Circadian rhythm sleep disorders: Toward a more precise definition and diagnosis. Chronobiol Int 16:213-222
21. Dagan Y, Sela H, Omer H, Hallis D, Dar R (1996) High prevalence of personality disorders among circadian rhythm sleep disorders (CRSD) patients. J Psychosom Res 41:357-363
22. Dagan Y, Stein D, Steinbock M, Yovel I, Hallis D (1998) Frequency of delayed sleep phase syndrome among hospitalized adolescent psychiatric patients. J Psychosom Res 45:15-20
23. de Bodinat C, Guardiola-Lemaitre B, Mocaer E, Renard P, Munoz C, Millan MJ (2010) Agomelatine, the first melatonergic antidepressant: Discovery, characterization and development. Nat Rev Drug Discov 9:628-642
24. de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: From adaptation to disease. Nat Rev Neurosci 6:463-475
25. Diorio D, Viau V, Meaney MJ (1993) The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-Adrenal responses to stress. J Neurosci 13:3839-3847
26. Eser D, Schule C, Romeo E, Baghai TC, di Michele F, Pasini A, Zwanzger P, Padberg F, Rupprecht R (2006) Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology 186:373-387
27. Fabian TJ, Dew MA, Pollock BG, Reynolds CF III, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD (2001) Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry 50:767-774
28. Findley DB, Leckman JF, Katsovich L, Lin H, Zhang H, Grantz H, Otka J, Lombroso PJ, King RA (2003) Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents ith Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 42:450-457
29. Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, Sceery W, Shaffer D (1988) Obsessive compulsive disorder in adolescence: An epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764-771
30. Fornaro M (2011) Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: A 3 month follow-up case series. Ann Gen Psychiatry 10:5
31. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989) The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011
32. Grados M, Wilcox HC (2007) Genetics of obsessive-compulsive disorder: A research update. Expert Rev Neurother 7:967-980
33. Grandin LD, Alloy LB, Abramson LY (2006) The social zeitgeber theory, circadian rhythms, and mood disorders: Review and evaluation. Clin Psychol Rev 26:679-694
34. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J (1996) Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: Relation to blood levels and the effects of age. J Clin Endocrinol Metab 81:3951-3960
35. Gustafsson PE, Gustafsson PA, Ivarsson T, Nelson N (2008) Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology 57:14-21
36. Herman JP, Ostrander MM, Mueller NK, Figueiredo H (2005) Limbic system mechanisms of stress regulation: Hypothalamo-pituitaryadrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29:1201-1213
37. Heuser I, Deuschle M, Luppa P, Schweiger U, Standhardt H, Weber B (1998) Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83:3130-3133
38. Hohagen F, Lis S, Krieger S, Winkelmann G, Riemann D, Fritsch-Montero R, Rey E, Aldenhoff J, Berger M (1994) Sleep EEG of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 243:273-278
39. Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein RJ, Murphy DL (1982) The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 39:1372-1377
40. Jenike MA, Baer L, Brotman AW, Goff DC, Minichiello WE, Regan NJ (1987) Obsessive-compulsive disorder, depression, and the dexamethasone suppression test. J Clin Psychopharmacol 7:182-184
41. Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E (2012) Circadian rhythms in the hypothalamo-pituitary-Adrenal (HPA) axis. Mol Cell Endocrinol 349:20-29
42. Khanna S, John JP, Reddy LP (2001) Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder. Psychoneuroendocrinology 26:209-223
43. Kluge M, Schussler P, Kunzel HE, Dresler M, Yassouridis A, Steiger A (2007a) Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res 41:928-933
44. Kluge M, Schussler P, Dresler M, Yassouridis A, Steiger A (2007b) Sleep onset REM periods in obsessive compulsive disorder. Psychiatry Res 152:29-35
45. Le Melledo JM, Baker GB (2002) Neuroactive steroids and anxiety disorders. J Psychiatry Neurosci 27:161-165
46. Le Melledo JM, Baker G (2004) Role of progesterone and other neuroactive steroids in anxiety disorders. Expert Rev Neurother 4:851-860
47. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ (1994) Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry 51:782-792
48. Lieberman JA, Kane JM, Sarantakos S, Cole K, Howard A, Borenstein M, Novacenko H, Puig-Antich J (1985) Dexamethasone suppression tests in patients with obsessive-compulsive disorder. Am J Psychiatry 142:747-751
49. Lucey JV, Barry S, Webb MG, Dinan TG (1992) The desipramineinduced growth hormone response and the dexamethasone suppression test in obsessive-compulsive disorder. Acta Psychiatr Scand 86:367-370
50. MacLullich AM, Ferguson KJ, Wardlaw JM, Starr JM, Deary IJ, Seckl JR (2006) Smaller left anterior cingulate cortex volumes are associated with impaired hypothalamic-pituitary-Adrenal axis regulation in healthy elderly men. J Clin Endocrinol Metab 91:1591-1594
51. Majewska MD (1992) Neurosteroids: Endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38:379-395
52. Majewska MD, Demirgoren S, Spivak CE, London ED (1990) The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res 526:143-146
53. Millet B, Touitou Y, Poirier MF, Bourdel MC, Amado I, Hantouche EG, Bogdan A, Olie JP (1999) Obsessive-compulsive disorder: Evaluation of clinical and biological circadian parameters during fluoxetine treatment. Psychopharmacology 146:268-274
54. Monnet FP, Mahe V, Robel P, Baulieu EE (1995) Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-Aspartate in the rat hippocampus. Proc Natl Acad Sci USA 92:3774-3778
55. Monteleone P, Catapano F, Del Buono G, Maj M (1994) Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 89: 411-415
56. Monteleone P, Catapano F, Tortorella A, Di Martino S, Maj M (1995) Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment. Psychoneuroendocrinology 20:763-770
57. Mukhopadhyay S, Drummond LM, Fineberg N (2004) A retrospective case note study of sleep in obsessive compulsive disorder. Eur Neuropsychopharmacol 14(Suppl 3):S312
58. Mukhopadhyay S, Fineberg NA, Drummond LM, Turner J, White S, Wulff K, Ghodse H (2008) Delayed sleep phase in severe obsessive-compulsive disorder: A systematic case-report survey. CNS Spectr 13:406-413
59. Nestadt G, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, LaBuda M, Walkup J, Grados M, Hoehn-Saric R (2000) A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 57: 358-363
60. Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J (2002) Treatment non-response in OCD: Methodological issues and operational definitions. Int J Neuropsychopharmacol 5:181-191
61. Pauls DL (2010) The genetics of obsessive-compulsive disorder: A review. Dialogues Clin Neurosci 12:149-163
62. Rapoport J, Elkins R, Langer DH, Sceery W, Buchsbaum MS, Gillin JC, Murphy DL, Zahn TP, Lake R, Ludlow C, Mendelson W (1981) Childhood obsessive-compulsive disorder. Am J Psychiatry 138:1545-1554
63. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ (1994) Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51:62-70
64. Reddy DS, Kulkarni SK (1997) Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752:61-71
65. Refinetti R, Menaker M (1992) The circadian rhythm of body temperature. Physiol Behav 51:613-637
66. Rosenberg DR, Keshavan MS, A.E. Bennett Research Award (1998) Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 43:623-640
67. Rupprecht R (1997) The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 31:297-314
68. Sanchez S, Sanchez C, Paredes SD, Cubero J, Rodriguez AB, Barriga C (2008) Circadian variations of serotonin in plasma and different brain regions of rats. Mol Cell Biochem 317:105-111
69. Schrader H, Bovim G, Sand T (1993) The prevalence of delayed and advanced sleep phase syndromes. J Sleep Res 2:51-55
70. Smits MG, Nagtegaal EE, van der HJ, Coenen AM, Kerkhof GA (2001) Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial. J Child Neurol 16:86-92
71. Sullivan GM, Coplan JD, Kent JM, Gorman JM (1999) The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46:1205-1218
72. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR (2004) Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 161:1049-1056
73. Szeszko PR, Ardekani BA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM, Lim KO (2005) White matter abnormalities in obsessive-compulsive disorder: A diffusion tensor imaging study. Arch Gen Psychiatry 62:782-790
74. Tarumi S, Tashiiro N (2004) Stress situations of daily living in patients with obsessive-compulsive disorder: A retrospective case note study. Psychol Rep 94:139-150
75. Toro J, Cervera M, Osejo E, Salamero M (1992) Obsessive-compulsive disorder in childhood and adolescence: A clinical study. J Child Psychol Psychiatry 33:1025-1037
76. Turner J, Drummond LM, Mukhopadhyay S, Ghodse H, White S, Pillay A, Fineberg NA (2007) A prospective study of delayed sleep phase syndrome in patients with severe resistant obsessive-compulsive disorder. World Psychiatry 6:108-111
77. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS (2003) Overactive action monitoring in obsessive-compulsive disorder: Evidence from functional magnetic resonance imaging. Psychol Sci 14:347-353
78. Vallejo J, Olivares J, Marcos T, Martinez-Osaba MJ, Ribera F, Bulbena A (1988) Dexamethasone suppression test and primary obsessional compulsive disorder. Compr Psychiatry 29:498-502
79. Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL, Cuffe SP (1994) Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 33:782-791
80. Viard A, Flament MF, Artiges E, Dehaene S, Naccache L, Cohen D, Mazet P, Mouren MC, Martinot JL (2005) Cognitive control in childhood-onset obsessive-compulsive disorder: A functional MRI study. Psychol Med 35:1007-1017
81. Walitza S, Wendland JR, Gruenblatt E, Warnke A, Sontag TA, Tucha O, Lange KW (2010) Genetics of early-onset obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 19:227-235
82. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ, The Cross National Collaborative Group (1994) The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry 55(Suppl):5-10
83. Weitzman ED, Czeisler CA, Coleman RM, Spielman AJ, Zimmerman JC, Dement W, Richardson G, Pollak CP (1981) Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry 38:737-746
84. Wulff K, Gatti S, Wettstein JG, Foster RG (2010) Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 11:589-599
85. Zammit GK (1997) Delayed sleep phase syndrome and related conditions. In: Pressman MR, Orr WC (eds) Understanding sleep. American Psychological Association, Washington DC